Health Canada Prioritizes Review of FILSUVEZ for EB-Related Wounds
As reported of The Manila Times, Health Canada has granted priority review to Chiesi Global Rare Diseases’ new drug submission for FILSUVEZ® (birch triterpenes) topical gel, proposed for treating wounds…